As widely expected by the pharmaceutical industry, seven pharmaceutical companies are releasing biosimilars of AbbVie's Humira. Boehringer Ingelheim's Cyltezo (adalimumab-adbm), an interchangeable ...
July 5 (Reuters) - South Korea's Celltrion Healthcare (091990.KQ), opens new tab has launched a copycat version to AbbVie Inc's (ABBV.N), opens new tab Humira at about a 5% discount, adding to the ...
Cimzia and Humira are both FDA-approved biologics that treat inflammatory conditions by preventing the immune system from attacking healthy cells. While both medications can cause injection site ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results